The Claim
Beta carotene supplementation at 15 mg daily is associated with an increased incidence of lung cancer in former smokers aged 50–85 with age-related macular degeneration, with a 2.0% incidence in the supplemented group versus 0.9% in the non-supplemented group (nominal P = .04).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among former smokers aged 50–85 with age-related macular degeneration, taking 15 mg of beta carotene daily is linked to a higher rate of lung cancer compared to not taking it, with 2.0% of supplement users developing lung cancer versus 0.9% of non-users.
See the scientific wording
Beta carotene supplementation (15 mg daily) is associated with an increased incidence of lung cancer in former smokers aged 50–85 with age-related macular degeneration, with 2.0% of those taking beta carotene developing lung cancer compared to 0.9% in those not taking it (nominal P = .04).
High-dose beta carotene reduces protective antioxidants in the eyes, which signals the body to increase its use of beta carotene in other tissues. In former smokers, this leads to excess beta carotene building up in the lungs, where it reacts with leftover tobacco toxins and creates harmful compounds that damage DNA in lung cells, causing cancer.
What the research says
1 studyIn a big study of older former smokers with eye disease, those who took beta carotene supplements were more likely to get lung cancer than those who didn’t — about 2 out of 100 vs. 1 out of 100. So yes, the supplement raised the risk.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.